TROV - TrovaGene, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.816
+0.011 (+1.354%)
As of 11:43AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.805
Open0.800
Bid0.816 x 6000
Ask0.820 x 300
Day's Range0.800 - 0.828
52 Week Range0.610 - 4.250
Volume161,140
Avg. Volume628,757
Market Cap31.09M
Beta-0.40
PE Ratio (TTM)-0.65
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube13 days ago

    ETFs with exposure to TrovaGene, Inc. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • When Will TrovaGene Inc (TROV) Run Out Of Cash?
    Simply Wall St.19 days ago

    When Will TrovaGene Inc (TROV) Run Out Of Cash?

    TrovaGene Inc (NASDAQ:TROV) announced a loss of -$36.81M in its most recent earnings update. Although some investors expected this, their belief in the path to profitability for TROV may beRead More...

  • What Does TrovaGene Inc’s (TROV) Share Price Indicate?
    Simply Wall St.last month

    What Does TrovaGene Inc’s (TROV) Share Price Indicate?

    TrovaGene Inc (NASDAQ:TROV), a pharmaceuticals, biotechnology and life sciences company based in United States, received a lot of attention from a substantial price movement on the NasdaqCM in the overRead More...

  • Capital Cube2 months ago

    ETFs with exposure to TrovaGene, Inc. : September 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TrovaGene, Inc. :TROV-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
    Capital Cube2 months ago

    TrovaGene, Inc. :TROV-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017

    Categories: Yahoo FinanceGet free summary analysis TrovaGene, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of TrovaGene, Inc. – Genomic Health, Inc., Biocept, Inc., Laboratory Corporation of America Holdings, Exact Sciences Corporation, Quest Diagnostics Incorporated, PerkinElmer, Inc. and QIAGEN NV (GHDX-US, BIOC-US, LH-US, EXAS-US, DGX-US, ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to TrovaGene, Inc. : June 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TrovaGene, Inc. :TROV-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube5 months ago

    TrovaGene, Inc. :TROV-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis TrovaGene, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of TrovaGene, Inc. – Genomic Health, Inc., Biocept, Inc., Laboratory Corporation of America Holdings, Exact Sciences Corporation, Quest Diagnostics Incorporated, PerkinElmer, Inc. and QIAGEN NV (GHDX-US, BIOC-US, LH-US, EXAS-US, DGX-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of TROV earnings conference call or presentation 10-May-17 9:00pm GMT

    Q1 2017 Trovagene Inc Earnings Call

  • Associated Press5 months ago

    Trovagene reports 1Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 32 cents. Losses, adjusted for restructuring costs, came to 26 cents per share. The molecular diagnostic company posted revenue of ...

  • Capital Cube6 months ago

    ETFs with exposure to TrovaGene, Inc. : April 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to TrovaGene, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TrovaGene, Inc. :TROV-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube7 months ago

    TrovaGene, Inc. :TROV-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis TrovaGene, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of TrovaGene, Inc. – Genomic Health, Inc., Biocept, Inc., Laboratory Corporation of America Holdings, Exact Sciences Corporation, Quest Diagnostics Incorporated, PerkinElmer, Inc., Enzo Biochem, Inc. and QIAGEN NV (GHDX-US, BIOC-US, ... Read more (Read more...)

  • TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4
    Zacks7 months ago

    TrovaGene (TROV) Reports Wider-than-Expected Loss in Q4

    TrovaGene Inc. (TROV) reported loss of 31 cents per share in the fourth quarter of 2016, 2 cents wider than the Zacks Consensus Estimate.

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of TROV earnings conference call or presentation 15-Mar-17 9:00pm GMT

    Q4 2016 Trovagene Inc Earnings Call

  • Associated Press7 months ago

    Trovagene reports 4Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 34 cents. Losses, adjusted for restructuring costs, were 31 cents per share. The molecular diagnostic company posted revenue of $68,000 ...

  • Capital Cube10 months ago

    ETFs with exposure to TrovaGene, Inc. : December 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Trovagene to Focus More on Liquid Biopsy Testing Market
    Zacks10 months ago

    Trovagene to Focus More on Liquid Biopsy Testing Market

    Trovagene, Inc. (TROV), recently announced that it will increase its focus on the global distribution of kits and systems to clinical research laboratories for the liquid biopsy oncology testing market.

  • Capital Cube10 months ago

    ETFs with exposure to TrovaGene, Inc. : December 8, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TrovaGene Inks Contract with Boreal Genomics, Stock Down
    Zacks11 months ago

    TrovaGene Inks Contract with Boreal Genomics, Stock Down

    TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.

  • Zacks11 months ago

    TrovaGene (TROV) Precision Cancer Monitoring Data Positive

    TrovaGene Inc. (TROV) recently announced encouraging data pertaining to its Precision Cancer Monitoring (PCM) technology for both urine and plasma EGFR mutation testing.

  • Capital Cube11 months ago

    ETFs with exposure to TrovaGene, Inc. : November 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • TrovaGene, Inc. :TROV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube11 months ago

    TrovaGene, Inc. :TROV-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis TrovaGene, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of TrovaGene, Inc. – Genomic Health, Inc., Biocept, Inc., Laboratory Corporation of America Holdings, Exact Sciences Corporation, Quest Diagnostics Incorporated, PerkinElmer, Inc. and QIAGEN NV (GHDX-US, BIOC-US, LH-US, EXAS-US, DGX-US, ... Read more (Read more...)

  • TrovaGene (TROV) Reports Wider-than-Expected Loss in Q3
    Zacks11 months ago

    TrovaGene (TROV) Reports Wider-than-Expected Loss in Q3

    TrovaGene Inc (TROV) reported loss of 34 cents per share in the third quarter of 2016, wider than the Zacks Consensus Estimate by 2 cents.

  • Thomson Reuters StreetEvents11 months ago

    Edited Transcript of TROV earnings conference call or presentation 9-Nov-16 10:00pm GMT

    Q3 2016 Trovagene Inc Earnings Call